Access cutting-edge endometriosis treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access endometriosis specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometriosis treatment provided free
A Phase 3 clinical trial of oral GnRH antagonist pre-treatment for women with endometriosis who are undergoing IVF, with a primary outcome of live birth rate. The investigators' central hypothesis is that in infertile woman with endometriosis undergoing in vitro fertilization-embryo transfer (IVF-ET), live birth rates will improve in those pretreated with GnRH antagonist compared to those not pretreated with GnRH antagonist.
Sponsor: Yale University
Check if you qualify for this endometriosis clinical trial in New Haven, CT
If you're searching for endometriosis treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometriosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.